FDA Clearance Tracker · P140017-S006
MELODY TRANSCATHETER PULMONARY VALVE , ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM (DS)
Last checked: Nov 20, 2026Latest source record: May 22, 2017 (this decision)Source: openFDAMethods & limitations
Decided
May 22, 2017
Approved
Time to decision
180 days
Received Nov 23, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
The decision
- FDA number
- P140017-S006
- Device name
- MELODY TRANSCATHETER PULMONARY VALVE , ENSEMBLE TRANSCATHETER VALVE DELIVERY SYSTEM (DS)
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Nov 23, 2016
- Decided
- May 22, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P140017
Device type
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for updates to the Melody Transcatheter Pulmonary Valve System Instructions for Use to reflect the final results of the Long-Term Follow-up Post-Approval Study.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.